Enoxaparin News
Guidelines to manage heparin shortage
Guidelines have been released to help manage patients needing anti-coagulation if there are shortages of heparin-based products.
Sanofi-Aventis could face antitrust charges if company loses Lovenox patent case
Even though the FDA has not approved any follow-on versions of Sanofi-Aventis’s anticoagulant Lovenox (enoxaparin), lawyers for generics makers have told Pharmawire that they will seek monetary damages in an antitrust case if...
Sanofi-Aventis Says Its Anticoagulant Clexane Gets Approval In Japan
Monday, pharmaceutical company, Sanofi-Aventis said its Clexane, the drug that prevents blood from clotting got marketing approval in Japan. The company also said the drug is particularly used in patients undergoing orthopaedic...
QMC nurse in durg lie struck off
An "untrustworthy and dishonest" hospital nurse has been struck off after failing to ensure a patient took vital anti-clotting drugs in the hours before he died of a heart attack.
Current and emerging therapies in the management of venothromboembolism
More deaths are attributed each year to venothromboembolism (VTE) than to motor vehicle accidents, breast cancer, and AIDS combined, but it remains under-recognized and undertreated. Prophylaxis is the most appropriate and...